Comparative Pharmacology
Head-to-head clinical analysis: CHOLAC versus SODIUM PICOSULFATE MAGNESIUM OXIDE AND ANHYDROUS CITRIC ACID.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CHOLAC versus SODIUM PICOSULFATE MAGNESIUM OXIDE AND ANHYDROUS CITRIC ACID.
CHOLAC vs SODIUM PICOSULFATE, MAGNESIUM OXIDE AND ANHYDROUS CITRIC ACID
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Lactulose is a synthetic disaccharide that is not absorbed in the small intestine. It is metabolized by colonic bacteria to short-chain fatty acids, primarily lactic acid and acetic acid, which lower the colonic pH. This acidification traps ammonia (NH3) as ammonium (NH4+) in the gut lumen, reducing serum ammonia levels. Additionally, the osmotic effect of lactulose draws water into the colon, producing a laxative effect.
Sodium picosulfate is a stimulant laxative that is converted by colonic bacteria to the active metabolite bis-(p-hydroxyphenyl)-pyridyl-2-methane, which acts on the colonic mucosa to stimulate peristalsis and increase water and electrolyte secretion. Magnesium oxide and citric acid react in solution to form magnesium citrate, an osmotic laxative that draws water into the intestinal lumen, increasing stool volume and promoting bowel evacuation.
15-30 mL (10-20 g lactulose) orally once daily, titrated to produce 2-3 soft stools per day; maximum dose 60 mL/day. For hepatic encephalopathy: 30-45 mL (20-30 g) orally 3-4 times daily, titrated to 2-3 soft stools per day.
Adults: 10 mg sodium picosulfate, 3.5 g magnesium oxide, and 10.97 g anhydrous citric acid (reconstituted in water) as a single oral dose, followed by clear liquids. Two doses may be used in a split-dose regimen: first dose evening before procedure, second dose day of procedure at least 5 hours prior.
None Documented
None Documented
0.5-1.5 hours for lactulose; active metabolites (e.g., acetic acid) have negligible systemic half-life due to rapid local metabolism.
Sodium picosulfate active metabolite BHPM: terminal half-life approximately 7.4 hours; clinical duration of laxative effect extends beyond half-life due to colonic residence.
Primarily fecal (biliary excretion of unchanged drug and metabolites); minimal renal excretion (<5%).
Sodium picosulfate is primarily excreted in feces (biliary/fecal elimination) as active metabolite BHPM; <5% renal. Magnesium oxide is excreted renally as magnesium ions; absorbed magnesium is eliminated via kidneys. Anhydrous citric acid is metabolized in the Krebs cycle; minimal renal excretion.
Category C
Category C
Laxative
Laxative